Publications

Detailed Information

The pNNx Heart Rate Variability Statistics: An Application to Neuroautonomic Dysfunction of Clozapine-Treated Subjects

DC Field Value Language
dc.contributor.authorKim, Jong-Hoon-
dc.contributor.authorYi, Sang Hoon-
dc.contributor.authorAhn, Yong Min-
dc.contributor.authorLee, Kyu Young-
dc.contributor.authorKim, Yong Sik-
dc.contributor.authorYang, Seung Ae-
dc.date.accessioned2012-07-05T00:52:01Z-
dc.date.available2012-07-05T00:52:01Z-
dc.date.issued2009-12-
dc.identifier.citationPSYCHIATRY INVESTIGATION; Vol.6 4; 294-298ko_KR
dc.identifier.issn1738-3684-
dc.identifier.urihttps://hdl.handle.net/10371/78529-
dc.description.abstractObjective The percentage Of Successive normal cardiac interbeat intervals greater than 50 msec (pNN50) is a widely used heart rate variability measure, which is useful in identifying the neuroautonomic dysfunction of psychiatric disorders. However, pNN50 is only one member of a larger family of pNNx statistics, where x is greater than 0 msec. The potential application of the general pNNx statistics has not yet been explored in the psychiatric field. The authors examined the pNNx statistics in clozapine-treated subjects and normal controls to evaluate the usefulness of the general pNNx statistics. Methods Sixty-one schizophrenic patients treated with clozapine and fifty-nine normal controls were evaluated. probability values for the differences between the groups at each pNN value (range: pNN1-pNN100) were calculated using data obtained from a 30-minute electrocardiogram. Results The conventional pNN50 and pNNx values with x<50 msec were all significantly lower in the patient group (p<0.05). The distinction between the two groups was more prominent at pNN values less than 50 msec than that observed at pNN50. The maximum separation between groups occurred at pNN5 (68.2 +/- 19.1 vs 22.5 +/- 20.5, p<10(-22)). Conclusion The pNNx with x<50 msec provided more robust discrimination between the groups than the conventional pNN50, suggesting the importance of analyzing very small variations of interbeat interval in discriminating normal and pathological heart rate patterns. The results also Suggest that the general pNNx statistics may be applied and useful in evaluating the neuroautonomic dysfunction in patients treated with clozapine, complementing the traditionally Computed pNN50 value. Psychiatry Invest 2009;6:294-298ko_KR
dc.description.sponsorshipThis study was supported in part by the
Brain Korea 21 project for Medicine, Dentistry, and Pharmacy (Seoul
National University) and by Grant No. 04-2006-0540 from Seoul National
University Hospital.
ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN NEUROPSYCHIATRIC ASSOCko_KR
dc.subjectHeart rate variabilityko_KR
dc.subjectNeuroautonomic dysfunctionko_KR
dc.subjectClozapineko_KR
dc.subjectpNNx statisticsko_KR
dc.subjectSchizophreniako_KR
dc.titleThe pNNx Heart Rate Variability Statistics: An Application to Neuroautonomic Dysfunction of Clozapine-Treated Subjectsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김종훈-
dc.contributor.AlternativeAuthor이상훈-
dc.contributor.AlternativeAuthor안용민-
dc.contributor.AlternativeAuthor이규영-
dc.contributor.AlternativeAuthor양승애-
dc.contributor.AlternativeAuthor김용식-
dc.identifier.doi10.4306/pi.2009.6.4.294-
dc.citation.journaltitlePSYCHIATRY INVESTIGATION-
dc.description.citedreferenceDuschek S, 2009, HYPERTENS RES, V32, P938, DOI 10.1038/hr.2009.115-
dc.description.citedreferenceLollgen D, 2009, MUSCLE NERVE, V39, P536, DOI 10.1002/mus.21242-
dc.description.citedreferenceSiepmann M, 2008, APPL PSYCHOPHYS BIOF, V33, P195, DOI 10.1007/s10484-008-9064-z-
dc.description.citedreferenceBar KB, 2008, J CLIN PSYCHOPHARM, V28, P694, DOI 10.1097/JCP.0b013e31818a6d25-
dc.description.citedreferenceBar KJ, 2008, PSYCHIAT RES, V157, P255, DOI 10.1016/j.psychres.2007.04.021-
dc.description.citedreferenceBar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012-
dc.description.citedreferenceBar KJ, 2007, SCHIZOPHR RES, V95, P115, DOI 10.1016/j.schres.2007.05.034-
dc.description.citedreferenceKim JH, 2006, EUR NEUROPSYCHOPHARM, V16, P459, DOI 10.1016/j.euroneuro.2005.11.003-
dc.description.citedreferenceMujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850-
dc.description.citedreferenceKIM W, 2005, J KOREAN NEUROPSYCHI, V44, P176-
dc.description.citedreferenceTank J, 2004, HYPERTENSION, V43, P1035, DOI 10.1161/01.HYP.0000125729.90521.94-
dc.description.citedreferenceKim JH, 2004, PROG NEURO-PSYCHOPH, V28, P371, DOI 10.1016/j.pnpbp.2003.11.007-
dc.description.citedreferenceMueck-Weymann M, 2004, CLIN AUTON RES, V14, P15, DOI 10.1007/s10286-004-0123-0-
dc.description.citedreferenceYeragani VK, 2003, PSYCHIAT RES, V121, P185, DOI 10.1016/S0165-1781(03)00235-X-
dc.description.citedreferenceAgelink MW, 2003, PHARMACOPSYCHIATRY, V36, P166-
dc.description.citedreferenceMietus JE, 2002, HEART, V88, P378-
dc.description.citedreferenceYeragani VK, 2002, BIOL PSYCHIAT, V52, P418-
dc.description.citedreferenceEschweiler GW, 2002, PHARMACOPSYCHIATRY, V35, P96-
dc.description.citedreferenceGoldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499-
dc.description.citedreferenceAnsakorpi H, 2002, J NEUROL NEUROSUR PS, V72, P26-
dc.description.citedreferenceMALASPINA D, 2002, CNS SPECTRUMS, V7, P53-
dc.description.citedreferenceMueck-Weymann M, 2002, DEPRESS ANXIETY, V16, P93, DOI 10.1002/da.10037-
dc.description.citedreferenceCohen H, 2001, BRIT J PSYCHIAT, V179, P167-
dc.description.citedreferenceHaapaniemi TH, 2001, J NEUROL NEUROSUR PS, V70, P305-
dc.description.citedreferenceCohen H, 2001, CLIN NEUROPHARMACOL, V24, P106-
dc.description.citedreferenceAgelink MW, 2001, J CLIN PSYCHOPHARM, V21, P8-
dc.description.citedreferenceToichi M, 1999, INT J PSYCHOPHYSIOL, V31, P147-
dc.description.citedreferenceMalaspina D, 1997, BIOL PSYCHIAT, V41, P612-
dc.description.citedreferenceKorpelainen JT, 1996, STROKE, V27, P2059-
dc.description.citedreferenceHALL RCW, 1995, PSYCHOSOMATICS, V36, P267-
dc.description.citedreferenceRECHLIN T, 1994, BIOL PSYCHIAT, V35, P888-
dc.description.citedreference*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P273-
dc.description.citedreferenceHUIKURI HV, 1990, AM J CARDIOL, V65, P391-
dc.description.citedreferenceBIGGER JT, 1988, AM J CARDIOL, V61, P208-
dc.description.citedreferenceKAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261-
dc.description.citedreferenceEWING DJ, 1984, BRIT HEART J, V52, P396-
dc.description.citedreferenceGUY W, 1976, ECDEU ASSESSMENT PSY-
dc.description.tc2-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share